Controlling cell movement using light-sensitive molecules
Optical Control of the Actin Cytoskeleton
This study is exploring a new way to use light to control how cells move and work, which could help develop better treatments for conditions like cancer and nerve disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10928168 on NIH RePORTER |
What this research studies
This research focuses on developing light-activated molecules that can manipulate the actin cytoskeleton, which is crucial for cell movement and function. By targeting specific proteins involved in cell structure and movement, the researchers aim to control how cells behave in various environments. The approach involves using photoswitchable compounds derived from natural products to influence cellular processes in different cell types, including cancer cells and neurons. This innovative method could lead to new therapies that precisely target cellular functions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to abnormal cell movement, such as cancer or certain neurological disorders.
Not a fit: Patients with stable conditions that do not involve issues with cell movement or function may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advanced treatments for diseases by enabling precise control over cell behavior.
How similar studies have performed: Previous research has shown promising results in manipulating cellular functions using similar light-sensitive approaches, indicating a potential for success in this novel application.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Trauner, Dirk Hartwig — University of Pennsylvania
- Study coordinator: Trauner, Dirk Hartwig
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.